Takeda Sues 3 Rivals Over Planned Heartburn Drug Generics
Takeda Pharmaceutical Co. Ltd. on Wednesday sued Sandoz Inc. and two other rivals in California federal court, accusing their planned generic versions of acid reflux treatment Dexilant of infringing a patent...To view the full article, register now.
Already a subscriber? Click here to view full article